✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals
Market Cap
₹30 Cr.
P/E
0.00
  • Medicamen Organics
  • JFL Life Sciences
  • Medistep Healthcare

FAQs on Medicamen Organics Ltd. Shareprice

Medicamen Organics has given lower returns compared to its competitors.
Medicamen Organics has grown at ~-55.94% over the last 1yrs while peers have grown at a median rate of -32.0%

Medicamen Organics is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Medicamen Organics is 0, while 3 year average PE is 17.95.
Also latest EV/EBITDA of Medicamen Organics is 417 while 3yr average is 22.69.

Growth Table

  • Medicamen Organics Ltd.
  • JFL Life Sciences
  • Medistep Healthcare

Balance Sheet

  • Medicamen Organics Ltd.
  • JFL Life Sciences
  • Medistep Healthcare

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Medicamen Organics Ltd.
  • JFL Life Sciences
  • Medistep Healthcare

Cash Flow

  • Medicamen Organics Ltd.
  • JFL Life Sciences
  • Medistep Healthcare

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Medicamen Organics Ltd.
  • JFL Life Sciences
  • Medistep Healthcare

Quarterly Results

  • Medicamen Organics Ltd.
  • JFL Life Sciences
  • Medistep Healthcare

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*

FAQs on Medicamen Organics Ltd. Financials

Medicamen Organics balance sheet is weak and might have solvency issues

Yes, The net debt of Medicamen Organics is increasing.
Latest net debt of Medicamen Organics is ₹12.99 Crs as of Mar-26.
This is greater than Mar-25 when it was ₹4.49 Crs.

The profit is oscillating.
The profit of Medicamen Organics is -₹4.02 Crs for TTM, ₹4.05 Crs for Mar 2025 and ₹2.62 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Medicamen Organics latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Accounts Receivable

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech